Last updated at 03 Jul 2024 01:50 AM
Director
DIN: 05138443
Natarajan Kumaran is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at RACE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05138443.Natarajan Kumaran is currently involved in 2 different roles. Their most recent position is with QRIGHT PHARMA PRIVATE LIMITED as a Individual Promoter. The first company Natarajan Kumaran was appointed to as a director was RACE PHARMACEUTICALS PRIVATE LIMITED. Natarajan Kumaran is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Natarajan Kumaran is currently associated with 3 companies in various capacities such as Director and Individual Promoter. They serve as a Director at RACE PHARMACEUTICALS PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 05138443.Natarajan Kumaran is currently involved in 2 different roles. Their most recent position is with QRIGHT PHARMA PRIVATE LIMITED as a Individual Promoter. The first company Natarajan Kumaran was appointed to as a director was RACE PHARMACEUTICALS PRIVATE LIMITED. Natarajan Kumaran is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
4
Male
India
Gain instant access to verified contact details.
Current Companies (3)
Current LLPs (0)
Past Companies (0)
3y 10m 1y 11m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| RACE PHARMACEUTICALS PRIVATE LIMITED | Director | 03-Jan-2007 |
| VERAX LIFESCIENCES PRIVATE LIMITED | Director | 16-May-2016 |
| QRIGHT PHARMA PRIVATE LIMITED | Individual Promoter | 18-Oct-2022 |
| QRIGHT PHARMA PRIVATE LIMITED | Director | 18-Oct-2022 |